Poly(amidoamine) (PAMAM) dendritic nanostructures for controlled site-specific delivery of acidic anti-inflammatory active ingredient.
about
Transepithelial transport and toxicity of PAMAM dendrimers: implications for oral drug deliveryCurrent understanding of interactions between nanoparticles and the immune systemDendrimers bind antioxidant polyphenols and cisplatin drugEvaluation of poly(amidoamine) dendrimers as potential carriers of iminodiacetic derivatives using solubility studies and 2D-NOESY NMR spectroscopy.Exploring dendrimer towards dual drug delivery: pH responsive simultaneous drug-release kinetics.Dendritic systems in drug delivery applications.Dendrimeric nanoarchitectures mediated transdermal and oral delivery of bioactivesUnderstanding specific and nonspecific toxicities: a requirement for the development of dendrimer-based pharmaceuticals.Designing dendrimers for drug delivery and imaging: pharmacokinetic considerations.Dendrimers and miktoarm polymers based multivalent nanocarriers for efficient and targeted drug delivery.Nanotherapeutic approaches for the treatment of rheumatoid arthritis.Understanding the correlation between in vitro and in vivo immunotoxicity tests for nanomedicines.Nanodrugs: pharmacokinetics and safety.Nanoencapsulation for drug deliveryEffect of surface capping on targeting potential of folate decorated poly (propylene imine) dendrimers.Impact of Dendrimers on Solubility of Hydrophobic Drug MoleculesA medusa-like β-cyclodextrin with 1-methyl-2-(2'-carboxyethyl) maleic anhydrides, a potential carrier for pH-sensitive drug delivery.Inhibition of hIAPP Amyloid Aggregation and Pancreatic β-Cell Toxicity by OH-Terminated PAMAM Dendrimer.Optimization of carboxylate-terminated poly(amidoamine) dendrimer-mediated cisplatin formulation.The protein corona of dendrimers: PAMAM binds and activates complement proteins in human plasma in a generation dependent mannerIntracellular macrophage uptake of rifampicin loaded mannosylated dendrimers
P2860
Q24616011-EA1AA936-BBC9-42A8-A2D1-3DDEEACF4BE4Q26345204-7B64FFF6-A574-463F-AB00-33988D7AF820Q27307187-8078DDD0-20FE-40F3-A5F0-8327040AF96DQ30577158-BA70852D-DF8F-421D-BD54-880E5C303C89Q34827321-CDE7A190-622C-4183-B2EB-0179429D009FQ36945843-AFF86F05-8C69-465A-9E10-7493E1B64C30Q37472758-06D6F813-BBB6-49CE-B870-188DE0654B7DQ37694413-96329E3F-92AB-4E32-BEF1-C44828B5956AQ37823446-F927CD1A-BE1F-4F3A-8073-D076251B285AQ37886750-E67B54A8-C391-48F8-B7AB-676F8CBE2D58Q37916426-E1E80652-FE43-4637-B949-B75535A084B1Q38112504-AF59ACF4-4E31-4620-B5AA-3C8EE3B9AA1CQ38193067-4B701BEB-8DDE-4C04-AD18-DDDD7F95C1D8Q38594967-C2416F4C-E1D2-4A72-B20E-491981DA25BFQ38962357-508F7E64-EF6D-415C-B363-2CF74BC71523Q39339379-39291A34-2F6F-486E-9398-5AFF26B13D95Q42800805-851AA761-7FDC-4AD4-9A5F-FEC5B66AA198Q50887393-DF72C1E4-B002-40FC-AEB9-34C67DA54A9FQ54594365-C14D5F3C-D86A-4B37-8F39-E49C94D91C13Q55407203-A1242B90-3BF5-4426-B214-C51B51411CB5Q57187420-DB317F59-CDD2-4769-897A-EA323DE2E0EE
P2860
Poly(amidoamine) (PAMAM) dendritic nanostructures for controlled site-specific delivery of acidic anti-inflammatory active ingredient.
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Poly(amidoamine) (PAMAM) dendr ...... nflammatory active ingredient.
@ast
Poly(amidoamine) (PAMAM) dendr ...... nflammatory active ingredient.
@en
type
label
Poly(amidoamine) (PAMAM) dendr ...... nflammatory active ingredient.
@ast
Poly(amidoamine) (PAMAM) dendr ...... nflammatory active ingredient.
@en
prefLabel
Poly(amidoamine) (PAMAM) dendr ...... nflammatory active ingredient.
@ast
Poly(amidoamine) (PAMAM) dendr ...... nflammatory active ingredient.
@en
P2093
P2860
P356
P1433
P1476
Poly(amidoamine) (PAMAM) dendr ...... nflammatory active ingredient.
@en
P2093
Abhay Singh Chauhan
Narendra Kumar Jain
Prakash Vamanrao Diwan
P2860
P2888
P304
P356
10.1208/PT060367
P407
P577
2005-10-27T00:00:00Z
P5875
P6179
1015104738